Latest Insider Transactions at Applied Therapeutics Inc. (APLT)
This section provides a real-time view of insider transactions for Applied Therapeutics Inc. (APLT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Applied Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Applied Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2024
|
Leslie D. Funtleyder Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,530
-4.64%
|
$67,650
$5.83 P/Share
|
|
Aug 22
2024
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
22,681
-2.25%
|
$113,405
$5.83 P/Share
|
|
Aug 14
2024
|
Shoshana Shendelman President and CEO |
SELL
Open market or private sale
|
Direct |
119,591
-2.49%
|
$597,955
$5.93 P/Share
|
|
Aug 13
2024
|
Shoshana Shendelman President and CEO |
SELL
Open market or private sale
|
Direct |
357,423
-6.92%
|
$2,144,538
$6.18 P/Share
|
|
Aug 12
2024
|
Shoshana Shendelman President and CEO |
SELL
Open market or private sale
|
Direct |
300,000
-5.49%
|
$1,500,000
$5.98 P/Share
|
|
Aug 05
2024
|
Shoshana Shendelman President and CEO |
BUY
Bona fide gift
|
Indirect |
747,886
+50.0%
|
-
|
|
Aug 05
2024
|
Shoshana Shendelman President and CEO |
SELL
Bona fide gift
|
Indirect |
747,886
-100.0%
|
-
|
|
Jun 06
2024
|
Shoshana Shendelman President and CEO |
SELL
Open market or private sale
|
Direct |
61,795
-1.62%
|
$247,180
$4.32 P/Share
|
|
Jun 06
2024
|
Leslie D. Funtleyder Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,980
-5.51%
|
$67,920
$4.32 P/Share
|
|
Jun 06
2024
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
22,003
-2.13%
|
$88,012
$4.32 P/Share
|
|
Jun 06
2024
|
Stacy J. Kanter |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+29.41%
|
-
|
|
Jun 06
2024
|
Joel S Marcus |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+8.28%
|
-
|
|
Jun 06
2024
|
Jay S Skyler |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+40.91%
|
-
|
|
Jun 06
2024
|
Teena Lerner |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+29.92%
|
-
|
|
Jun 05
2024
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
150,000
-2.5%
|
$600,000
$4.24 P/Share
|
|
Jun 04
2024
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
150,000
-2.44%
|
$600,000
$4.21 P/Share
|
|
Apr 12
2024
|
Corwin Dale Hooks Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+50.0%
|
-
|
|
Mar 14
2024
|
Shoshana Shendelman President and CEO |
SELL
Open market or private sale
|
Direct |
318,573
-7.7%
|
$1,592,865
$5.39 P/Share
|
|
Mar 14
2024
|
Adam Hansard Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
48,871
-6.25%
|
$244,355
$5.39 P/Share
|
|
Mar 14
2024
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
110,804
-9.7%
|
$554,020
$5.39 P/Share
|
|
Mar 14
2024
|
Leslie D. Funtleyder Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
28,727
-8.52%
|
$143,635
$5.39 P/Share
|
|
Dec 28
2023
|
Constantine Chinoporos Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+50.0%
|
-
|
|
Dec 21
2023
|
Adam Hansard Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+33.85%
|
-
|
|
Dec 21
2023
|
Riccardo Perfetti Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+28.26%
|
-
|
|
Dec 21
2023
|
Shoshana Shendelman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,540,000
+16.27%
|
-
|
|
Dec 01
2023
|
Stacy J. Kanter |
BUY
Open market or private purchase
|
Direct |
30,000
+32.26%
|
$60,000
$2.18 P/Share
|
|
Nov 30
2023
|
Adam Hansard Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
965
-0.25%
|
$965
$1.97 P/Share
|
|
Nov 30
2023
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,583
-0.23%
|
$1,583
$1.97 P/Share
|
|
Nov 30
2023
|
Shoshana Shendelman President and CEO |
SELL
Open market or private sale
|
Direct |
3,968
-0.15%
|
$3,968
$1.97 P/Share
|
|
Nov 29
2023
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
575,000
-73.81%
|
-
|
|
Nov 29
2023
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
575,000
+8.54%
|
-
|
|
Nov 20
2023
|
Leslie D. Funtleyder Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+47.08%
|
-
|
|
Nov 03
2023
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
143,450
-2.51%
|
$286,900
$2.31 P/Share
|
|
Nov 02
2023
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
103,808
-1.78%
|
$207,616
$2.32 P/Share
|
|
Nov 01
2023
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
172,742
-2.88%
|
$345,484
$2.36 P/Share
|
|
Oct 31
2023
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
155,000
-2.52%
|
$310,000
$2.41 P/Share
|
|
Oct 12
2023
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,600,000
-67.26%
|
-
|
|
Oct 12
2023
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,600,000
+20.63%
|
-
|
|
Sep 27
2023
|
Adam Hansard Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
9,720
-2.48%
|
$19,440
$2.7 P/Share
|
|
Sep 27
2023
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,932
-1.55%
|
$21,864
$2.7 P/Share
|
|
Sep 27
2023
|
Shoshana Shendelman President and CEO |
SELL
Open market or private sale
|
Direct |
115,632
-4.26%
|
$231,264
$2.7 P/Share
|
|
Sep 15
2023
|
Joel S Marcus |
BUY
Exercise of conversion of derivative security
|
Direct |
12,375
+2.66%
|
$12,375
$1.05 P/Share
|
|
Jun 06
2023
|
Leslie D. Funtleyder Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+35.0%
|
-
|
|
Jun 06
2023
|
Stacy J. Kanter |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+37.74%
|
-
|
|
Jun 06
2023
|
Teena Lerner |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+24.87%
|
-
|
|
Jun 06
2023
|
Joel S Marcus |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+4.34%
|
-
|
|
Jun 06
2023
|
Jay S Skyler |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Jan 11
2023
|
Adam Hansard Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+43.32%
|
-
|
|
Jan 11
2023
|
Adam Hansard Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,495
-4.64%
|
$0
$0.91 P/Share
|
|
Jan 11
2023
|
Riccardo Perfetti Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
550,000
+43.83%
|
-
|